Little-known Ignyta (RXDX) has gotten real attention from healthcare investors following some fairly impressive results at ASCO last week.
Little-known Ignyta (RXDX) has gotten real attention from healthcare investors following some fairly impressive results at ASCO last week.
Please to comment